Data Microdosing Safety 
Cannabis Law Report
AUGUST 23, 2022
(CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) (“Silo Wellness” or the “Company”), a leading global psychedelics company, is pleased to announce that it has opened its first ecotourism microdosing psilocybin resort and retreat center at Go Natural Jamaica in Long Bay, Portland, Jamaica. gram microdose. .
Cannabis Law Report
DECEMBER 2, 2021
The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. Our trial is based on low or microdosing, which is hypothesized to potentially have a promising effect on Alzheimer’s patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Marijuana Packaging
OCTOBER 4, 2018
Microdosing can provide a bit of a safety net if the experience is different than we had imagined but this still doesn’t give us control over the actual direction of the effects. New Frontier Data, for example, calls what we’ve done Cannabis 2.0.” One to One.
Cannabis Law Report
FEBRUARY 9, 2022
But this is the first time Oregonians have been allowed to see some of the nuts and bolts of what some predict could grow into a billion-dollar industry nationally, according to Data Bridge Market Research. There are also draft rules on how facilitators will be trained to sit with people taking psilocybin to ensure safety.
The Cannigma
JULY 3, 2023
Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future. They found that it could be used in sessions to promote trust and safety, helping patients to open up and process traumatic experiences.
The Cannigma
FEBRUARY 3, 2022
We find out how women and other estrogen-predominant people react differently to cannabis than men and those with more testosterone, and why microdosing is far more effective for the former. That’s always the struggle we have when people want data and research and medical research to establish exactly how something works.
Cannabis Law Report
JUNE 4, 2021
Paul is the author of the book Microdosing Psychedelics: A Practical Guide to Upgrade Your Life and the founder and CEO of Third Wave and co-founder of Synthesis. Through its discovery platform, Delix has identified a class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles.
Expert insights. Personalized for you.
52 
Let's personalize your content